Here's Why Mirum Pharmaceuticals Rocketed 240% in December
It appears the FDA is willing to work with Mirium to get maralixibat approved as quickly as possible.
Mirum Pharmaceuticals, Inc.(MIRM)
Nasdaq Global Market
MIRM
$16.29
-$1.61
-9.0%
Price as of March 4, 2021, 9:00 p.m. EST
View Interactive MIRM Charts
Mirum Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops therapies for the treating of cholestatic liver diseases. Mirum Pharmaceuticals serves patients in the United States.
Interactive Chart
News & Analysis: Mirum Pharmaceuticals, Inc.
Here's Why Mirum Pharmaceuticals' Stock Jumped in December
This newly public drug developer tripled its stock price in November following positive FDA news.
